These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27592160)

  • 1. Effect of an antimicrobial stewardship intervention on outcomes for patients with Clostridium difficile infection.
    Welch HK; Nagel JL; Patel TS; Gandhi TN; Chen B; De Leon J; Chenoweth CE; Washer LL; Rao K; Eschenauer GA
    Am J Infect Control; 2016 Dec; 44(12):1539-1543. PubMed ID: 27592160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection.
    Brumley PE; Malani AN; Kabara JJ; Pisani J; Collins CD
    J Antimicrob Chemother; 2016 Mar; 71(3):836-40. PubMed ID: 26661392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
    Chia BY; Teo JQ; Lee W; Liew YX; Ee RP; Chlebicki MP; Oon LL; Kwa AL
    J Glob Antimicrob Resist; 2019 Jun; 17():312-315. PubMed ID: 30682564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
    Bass SN; Bauer SR; Neuner EA; Lam SW
    J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
    Lam SW; Bass SN; Neuner EA; Bauer SR
    Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
    Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
    J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
    Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
    Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
    Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
    J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secular trends in the epidemiology of Clostridium difficile infection (CDI) at a tertiary care hospital in Barcelona, 2006-2015: A prospective observational study.
    Larrainzar-Coghen T; Rodríguez-Pardo D; Fernández-Hidalgo N; Puig-Asensio M; Pigrau C; Ferrer C; Rodríguez V; Bartolomé R; Campany D; Almirante B
    Anaerobe; 2018 Jun; 51():54-60. PubMed ID: 29655966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia.
    Foolad F; Huang AM; Nguyen CT; Colyer L; Lim M; Grieger J; Li J; Revolinski S; Mack M; Gandhi T; Wainaina JN; Eschenauer G; Patel TS; Marshall VD; Nagel J
    J Antimicrob Chemother; 2018 May; 73(5):1402-1407. PubMed ID: 29462306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of real-time notification of Clostridium difficile test results and early initiation of effective antimicrobial therapy.
    Polen CB; Judd WR; Ratliff PD; King GS
    Am J Infect Control; 2018 May; 46(5):538-541. PubMed ID: 29305281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antimicrobial stewardship interventions on Clostridium difficile infection and clinical outcomes: segmented regression analyses.
    Patton A; Davey P; Harbarth S; Nathwani D; Sneddon J; Marwick CA
    J Antimicrob Chemother; 2018 Feb; 73(2):517-526. PubMed ID: 29177477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.